NDC 66993-0456-30
DAPAGLIFLOZIN 5 mg/1 TABLET, FILM COATED
Available — 2-Day Shipping
NDC
66993-0456-30
Generic Name
DAPAGLIFLOZIN
Brand Name
DAPAGLIFLOZIN
Strength
5 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Package Size
—
Labeler
Prasco Laboratories
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE DAPAGLIFLOZIN TABLETS are indicated: • To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression. • To reduce the risk of CV death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure. • To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All DAPAGLIFLOZIN Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other DAPAGLIFLOZIN NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 66993-0456-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).